Home Tags United States

Tag: United States

supporting-nh-and-finding-common-ground-nsights-from-francis-collins

Supporting NIH and Finding Common Ground: Insights from Francis Collins

Interview with Dr. Francis CollinsIn a recent interview on the "What the Health?" podcast, Dr. Francis Collins, former director of the National Institutes of Health (NIH), shared his insights on the vital role of...
expanding-medicare-coverage-for-obesity-medications-a-necessity

Expanding Medicare Coverage for Obesity Medications: A Necessity

Expanding Medicare Coverage for Obesity Medications: An Imperative ChangeIn a groundbreaking move, the Congressional Budget Office (CBO) recently delved into estimating the potential budgetary impacts of providing Medicare coverage for obesity treatments for older...
federal-ntervention-needed-to-address-ssues-with-pulse-oximeters-researchers-suggest-legal-action

Federal Intervention Needed to Address Issues with Pulse Oximeters: Researchers Suggest Legal Action

Federal Intervention Urgently Needed to Address Pulse Oximeter Issues: Legal Action SuggestedA groundbreaking study published in JAMA has shed light on the glaring disparities in the performance of pulse oximeters on individuals with darker...
top-fda-ssues-to-monitor-during-trump-administration-3-key-areas

Top FDA Issues to Monitor During Trump Administration: 3 Key Areas

Key Changes in FDA Under Trump Administration 2025 is shaping up to be a pivotal year for the Food and Drug Administration (FDA) with the imminent leadership changes on the horizon. With Donald Trump set...
top-first-opinion-essays-of-2024-reader-favorites-and-must-reads

Top First Opinion Essays of 2024: Reader Favorites and Must-Reads

Top First Opinion Essays of 2024: Reader Favorites and Must-ReadsIn a year that promised to be eventful due to the U.S. presidential election, 2024 took a surprising turn, especially in the realms of health,...
new-title-axsome-submits-alzheimers-disease-drug-for-fda-approval-after-phase-3-trials

Axsome submits Alzheimer’s disease drug for FDA approval after Phase 3 trials

Axsome Submits Alzheimer’s Disease Drug for FDA Approval Axsome Therapeutics, a New York-based biotech company, is forging ahead with its plans to seek FDA approval for its Alzheimer’s disease treatment, AXS-05, following results from Phase...
top-stat-stories-overlooked-in-2024-a-recap-of-key-healthcare-news

Top STAT Stories Overlooked in 2024: A Recap of Key Healthcare News

Top STAT Stories Overlooked in 2024: A Recap of Key Healthcare NewsIn the fast-paced world of healthcare news, it's easy to overlook some of the most impactful and groundbreaking stories. This year, STAT has...
overlooked-topics-in-2024-long-covid-a-obsession-and-trust

Overlooked Topics in 2024: Long Covid, AI Obsession, and Trust

Long Covid, AI Obsession, and Trust: The Overlooked Topics of 2024In the bustling world of life sciences, it's easy for important topics to slip through the cracks. Despite the best efforts of experts and...
aetna-lawsuit-against-radiology-group-for-fraudulent-billing-and-arbitration-abuse

Aetna Lawsuit Against Radiology Group for Fraudulent Billing and Arbitration Abuse

Aetna, the health insurance giant owned by CVS Health, has filed a lawsuit against Radiology Partners, one of the largest networks of radiology practices in the country, for alleged fraudulent billing practices and abuse...
scientists-prepare-for-potential-changes-in-health-funding-under-trump-administration

Scientists Prepare for Potential Changes in Health Funding Under Trump Administration

Scientists Brace for Health Funding Changes Amidst Trump Administration ReshuffleIn the wake of the recent White House reshuffling, scientists and healthcare professionals find themselves on the edge of uncertainty as the new administration's stance...